The Newsroom of HealthMyne

HealthMyne Newsroom Press Releases

  • Published on March 21, 2019 - 16:50 GMT

    FirstHealth of the Carolinas Selects HealthMyne

    FirstHealth will initially implement HealthMyne to advance its Lung Cancer Screening Program and streamline tumor conference collaboration MADISON, WI, USA, March 21, 2019 /⁨EINPresswire.com⁩/ -- HealthMyne Inc., a company focused on delivering quantitative imaging decision support for radiology and oncology, was recently selected by FirstHealth of the Carolinas to advance multiple oncology-related programs, including lung cancer screening and tumor conferences. FirstHealth is the first in the region to …

    Distribution channels: Healthcare & Pharmaceuticals Industry ...
  • Published on September 7, 2018 - 15:53 GMT

    HealthMyne Enters Joint Development Agreement with Mayo Clinic

    Mayo Clinic Evaluates Therapy Response Assessment Module of HealthMyne QIDS Platform MADISON, WI, UNITED STATES, September 7, 2018 /⁨EINPresswire.com⁩/ -- HealthMyne has signed a joint development agreement with Mayo Clinic to evaluate the Quantitative Imaging Decision Support (QIDS)® platform in their Scottsdale, AZ facility for Therapy Response Assessments, which allows for a standardized method of determining the effectiveness of various treatment protocols used in cancer care. In current practice, due …

    Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...
  • Published on August 21, 2018 - 15:30 GMT

    Cancer Screening Module in Latest Version of HealthMyne QIDS Platform Automates Patient Tracking to Improve Care

    QIDS 5 aims to achieve better outcomes through earlier diagnosis and treatment MADISON, WI, UNITED STATES, August 21, 2018 /⁨EINPresswire.com⁩/ -- HealthMyne announced the release of Quantitative Imaging Decision Support (QIDS)™ 5 featuring a new, automated Cancer Screening Module for tracking, communicating and reporting on patients who may be at a higher risk for developing cancer. QIDS 5 debuts dramatic changes to the platform’s Rapid Precise Metrics (RPM) workflow, improving usability and accuracy. The …

    Distribution channels: Healthcare & Pharmaceuticals Industry ...
  • Published on November 15, 2017 - 20:49 GMT

    HealthMyne Brings More Value to Every Oncology Read at the 2017 RSNA Conference

    Because every cancer patient’s story starts with an image MADISON, WISCONSIN, USA, November 15, 2017 /EINPresswire.com/ -- Attendees of the 2017 RSNA conference can learn how easy it is to accelerate their reads and elevate their reports by including quantitative data on every oncology read by visiting the HealthMyne booth, #4960. Even if a patient and their doctor have an idea that something is wrong, the story only begins when a radiologist declares that an abnormality seen on an image is cancer. The …

    Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...
  • Published on October 12, 2017 - 22:04 GMT

    New HealthMyne QIDS 3.0 Platform Addresses Incidental Findings Workflow

    Timely follow up means earlier treatment, better outcomes, and substantial cost savings MADISON, WI, USA, October 12, 2017 /EINPresswire.com/ -- Incidental lesions are discovered in up to 30% of imaging studies, yet follow up is generally poor. It is well known that the earlier cancer is detected, the higher the probability of long-term survival. Additionally, costs for cancer treatment increase dramatically when started in later stages of the disease. In their continued effort to provide improved patient …

    Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...
Contact
Neal Miller
HealthMyne
6088332610
Share This Newsroom
Company/Organization
HealthMyne
918 Deming Way
Madison, Wisconsin, 53717
United States
6088332610
Visit Website
About

HealthMyne, Inc. (HM; Madison, WI) is focused on delivering Quantitative Imaging Decision Support (QIDS)® for Radiology and Oncology to U.S.-based multi-hospital systems with expansion to non-U.S. markets and other clinical specialties over time. The company’s FDA-cleared software’s proprietary algorithms automate the extraction of quantitative imaging metrics at the Point-of-Read, greatly reducing inter- and intra-reader variability and making evidence-based metrics including volume, density, mass, doubling-times, heterogeneity, and others available at the Point-of-Care. These volumetric measurements are combined with clinical information from the EMR, PACS, Radiation Therapy and other systems to drive transformed CDS workflow modules (Cancer Screening/Tumor Conference/Therapy Response/Incidental Findings/Thoracic/others in development), actionable quantitative reports, and an integrated imaging and clinical patient-centric dashboard (PatientCare Timeline®) to optimize collaboration among the multidisciplinary care team. Additionally, the platform’s discoverable database supports the Point-of-Discovery by allowing data mining and AI-based application development for Precision Medicine and Big Data initiatives. QIDS facilitates innovative clinical, translational, and commercial research for healthcare systems, research organizations, and pharmaceutical/biotech companies.